Interestingly, while the relationship between eEF2 K expression and RFS was not statistically significant in ER(-), PR(-), HER2(-) patients (HR = 1.43, log-rank p = 0.22), a notable trend was observed.
← all excerpts
Development of silver-based hybrid nanoparticles loaded with eEF2 K-siRNA and quercetin against triple-negative breast cancer.
1
—
—